Works matching IS 09697063 AND DT 2012 AND VI 20 AND IP 3
Results: 28
CML -- Leukemia & Lymphoma Reader Survey.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2012, v. 20, n. 3, p. 107
- Publication type:
- Article
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.
- Published in:
- 2012
- Publication type:
- Opinion
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.
- Published in:
- 2012
- Publication type:
- Opinion
[1] A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis/[2] JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.
- Published in:
- 2012
- Publication type:
- Opinion
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first line dasatinib.
- Published in:
- 2012
- Publication type:
- Opinion
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the National Cancer Research Institute CLL206 trial.
- Published in:
- 2012
- Publication type:
- Opinion
Somatic STAT3 mutations in large granular lymphocytic leukemia.
- Published in:
- 2012
- Publication type:
- Opinion
EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience.
- Published in:
- 2012
- Publication type:
- Opinion
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT.
- Published in:
- 2012
- Publication type:
- Opinion
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.
- Published in:
- 2012
- Publication type:
- Opinion
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and microRNA expression signatures.
- Published in:
- 2012
- Publication type:
- Opinion
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
- Published in:
- 2012
- Publication type:
- Opinion
Activating mutations of the fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia.
- Published in:
- 2012
- Publication type:
- Opinion
Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.
- Published in:
- 2012
- Publication type:
- Opinion
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized Phase III study.
- Published in:
- 2012
- Publication type:
- Opinion
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
- Published in:
- 2012
- Publication type:
- Opinion
Impact of immune modulation with in vivo T cell depletion and myleoablative total body irradiation conditioning regimen on outcomes after unrelated donor transplantation for acute lymphoblastic leukemia in children.
- Published in:
- 2012
- Publication type:
- Opinion
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
- Published in:
- 2012
- Publication type:
- Opinion
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL.
- Published in:
- 2012
- Publication type:
- Opinion
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
- Published in:
- 2012
- Publication type:
- Opinion
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
- Published in:
- 2012
- Publication type:
- Opinion
Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.
- Published in:
- 2012
- Publication type:
- Opinion
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study.
- Published in:
- 2012
- Publication type:
- Opinion
Expression of COX-2 on Reed--Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.
- Published in:
- 2012
- Publication type:
- Opinion
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.
- Published in:
- 2012
- Publication type:
- Opinion
Results of a pivotal Phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.
- Published in:
- 2012
- Publication type:
- Opinion
Emerging Therapies for Follicular Lymphoma.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2012, v. 20, n. 3, p. 73
- By:
- Publication type:
- Article
Foreword.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2012, v. 20, n. 3, p. 73
- By:
- Publication type:
- Article